An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...

The melding of visual information (microscopic and X-ray images, CT and MRI scans, for example) with text (exam notes, ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Ryan Nguyen, DO, University of Illinois Chicago, highlights the importance of personalized care for patients who have non–small cell lung cancer (NSCLC) and the potential of artificial intelligence ...

A new study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of University of Pennsylvania researchers demonstrates that a first-of-its-kind platform using artificial ...

A discussion with Campbell Rogers, MD, regarding advances in AI technology for prevention and management of coronary artery disease.

Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it has raised US$11 million in Series A funding ...

PD-1 x VEGF antibodies show potential to surpass checkpoint inhibitors as standard-of-care in multiple oncology indications• NAYA aiming to ...

According to the latest study from BCC Research, "Artificial Intelligence (AI) in Cancer" is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth ...